•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.ADARx Pharmaceuticals, Inc. (ADRX) Presents at UBS Global Biopharma Conference 2026 Transcript
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering
First Look: Disney Layoffs, Apple Smart Home Launch, Goldman CEO Talks
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering